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Supplemental Figure 1. Metastatic stem cells vs tumor-initiating cells. Related to Figure 1. (A) Tumors 
generated using FACS-sorted ALDHhigh and ALDHlow MMTV-PyMT cells were digested and re-analysed again 
using the AldeFluor assay (n=5 independent tumors, Mann-Whitney test). (B) Tumors generated using FACS-
sorted ALDHhigh and ALDHlow were pulverised in liquid nitrogen, RNA was extracted and qPCRs were performed 
to evaluate the expression of Aldh1a3 transcripts (n=5 independent tumors, unpaired Student's t test). (C) Cancer 
stem cell frequency with confidence intervals of ALDHhigh and ALDHlow cells or CD24+CD90+/CD24+CD90- 
shown in Figure 1B, 1D and 1E. (D) Metastatic index of CD90-depleted tumors vs CD90+ cells containing tumors 
was calculated as the tumor weight (g) divided by the number of metastatic foci in the lungs (n=62 control and 






































Supplemental Figure 2. Characterization of CSC. Related to Figure 2. (A) qPCR comparing attached vs 
sphere cultures of MMTV-PyMT cells derived from the same tumors (n=8 independent tumors, paired Student's 
t test). (B) MMTV-PyMT tumors were digested and cells were plated either in 2D or 3D cultures. FACS analyses 
show that tumors plated as spheres have a higher frequency of ALDHhigh cells (n=7 independent tumors, paired 






































Supplemental Figure 3. Inhibition of TGFBR1 leads to an increase in the number of TIC. Related to Figure 
3. (A) Tumor cells were obtained from fresh MMTV-PyMT tumors, grown overnight in collagen-coated plates 
and then seeded as spheres (104 cells/well) in presence of either 2 µM Ly2157299 or DMSO. Spheres were 
counted 10 days later (n=20 DMSO, n=19 Ly, for 3 independent tumors, unpaired Student's t test). (B, C) 4T1 
(n= 12 DMSO, n=12 SB, n=5 TGFb3) and MMTV-Wnt1 cells (n=22 DMSO, n=11 SB, n=11 TGFb3) were plated 
as spheres (104 or 5x103 cells/well and 104 cells/well, respectively) and treated with 2 µM SB431542, 1 ng/ml 
TGFb3 or DMSO. Spheres were counted 7-10 days later (One-way ANOVA and Fisher's LSD, scale bar 100 µm). 
(D-F) Human breast cancer tissue was digested with collagenase and seeded directly in ultralow attachment plates 
with media containing DMSO, 2 µM SB431542, 2 µM Ly2157299 or 1 ng/ml TGFb3. Spheres were counted one 
week later (One-way ANOVA and Fisher's LSD). (G) Tumor cells were obtained from fresh MMTV-PyMT 
tumors, grown overnight in collagen-coated plates and then seeded as spheres (104 cells/well) in presence or 
absence of 500 ng of noggin. Spheres were counted 10 days later (n=48 DMSO, n=24 noggin, for 4 independent 
tumors, unpaired Student's t test). (H) Tumor cells were obtained from fresh MMTV-PyMT tumors, grown 
overnight in collagen-coated plates, trypsinized and infected with lentiviruses containing either the mock or a 
TGFBR2 decoy receptor (sTRII), selected and seeded in ULA plates. Spheres were counted 10 days later (n=48 
ctrl, n=46 sTRII, for 2 independent tumors, unpaired Student's t test). (I) Spheres were collected by centrifugation 
and protein extracts were subjected to Western blot analysis of pSMAD2 to test the TGFb pathway activation. 
 
 
Supplemental Figure 4. Inhibition of TGFBR1 decreases metastasis but increases tumor initiation 
potential. Related to Figure 4. (A) Fresh MMTV-PyMT tumor-derived cells were infected in suspension with 
lentiviruses containing the Tgfbr1 short hairpins. The expression was induced treating the cells with with 1µg/ml 
doxycycline for 48h. The graphs show the normalized mRNA expression levels for Tgfbr1 in activated vs non-
activated cells. (B, C) 4T1 cells infected with a shTgfbr1 were grafted orthotopically into BALB/c mice and one 
group was given doxycycline (1 mg/ml) in the drinking water for the duration of the experiment. Both groups 
formed equally sized tumors, but downregulation of Tgfbr1 led to a significant decrease in lung metastases (n=5, 
unpaired Student's t test). (D) MMTV-PyMT cells were assayed for MTT upon treatment with either 2 µM 
SB431542 or DMSO (n=5 independent tumors, paired Student's t test). 
 
 Supplemental Experimental Procedures 
 
Antibodies and reagents 
CD90.1 (HIS51), CD90.2 (53-2.1), CD24 (M1/69), eBioscience; Ter119, CD31 (MEC13.3), CD45 (30-F11), 
Biolegend; Cytokeratin 14 (Covance); pSMAD2, E-Cadherin (Cell Signaling); a-SMA, b-Tubulin (Sigma); 
Vimentin (Lifespan Biosciences); SB431542 (Stem Cell Technologies); Ly2157299 (Selleckchem), TGFb 
(Promega). Both small molecules were dissolved using DMSO and stocked at 10 mM. The plasmids containing 
the short hairpins for Tgfbr1 were produced by classical molecular cloning and subcloned into pRRL vectors 
containing a doxycycline inducible tet system and a blasticidin resistance gene for mammalian selection. The 
sequences of the hairpins are (5'-3'): Alk5_1535: TTAATTCGCAAAGCTGTCAGCC; Alk5_777: 
AGAAGAGAATATCTTCACAGCA; Alk5_825: TACAGTCTGATAAATCTCTGCC.  
  
 
Mouse work extended 
Orthotopic transplants 
To generate orthotopic transplants of MMTV-PyMT tumor cells, FVB/N mice were injected with 106 PyMT cells 
resuspended in 50 µl of PBS in the 4th mammary fat pad using an insulin syringe (26G). 4T1 tumors were 
generated by injecting 2.5x105 cells in the 4th mammary fat pad of BALB/c mice using an insulin syringe (26G). 
Metastatic foci in the lungs were counted using a Leica M125 stereomicroscope. 
 
Tail vein injections  
Mice were warmed by placing the cage under an IR light bulb. One mouse at a time was placed in a tube rodent 
holder for tail vein injection, with the tail outside of the tube. The tail was cleaned with 70% ethanol. The IR light 
bulb was placed above the tail to cause the veins to dilate. MMTV-PyMT tumor cells (5x105 per mouse) were 
resuspended in PBS and injected very slowly in a 100 µl volume into one of the two tail veins using an insulin 
syringe (26G needle). The spot of injection was then compressed with a tissue to make sure the tail was not 
bleeding. Mice were returned to the cage and kept for observation for 15 min. Metastatic foci in the lungs were 
counted after 3-5 weeks using a Leica M125 stereomicroscope. 
 
Cell culture 
Mouse tumor tissue was dissociated mechanically, followed by an incubation with 1:66 Liberase TH (Roche) and 
DNAse (10 mg/ml) at 37ºC for 1 hour. Cells were then washed twice in 2 mM EDTA in PBS and once in PBS 
and then plated in collagen-coated plates (HBSS, BSA 100 mg/ml, HEPES 1M pH 6.5 and bovine collagen 
biomatrix by Cell Systems). Cells were grown in DMEM:F12 (Gibco) supplemented with 2% FBS, 1% 
penicillin/streptomycin 20 ng/ml EGF (Invitrogen) and 10 µg/ml insulin (Invitrogen) and let attach overnight. 
4T1 cells were obtained from the ATCC and grown as recommended. Human breast tumor tissue was obtained 
under informed consent from patients undergoing breast surgery (tumorectomy or mastectomy) for an untreated 
breast cancer. Tissues were collected in HBSS+2% FBS+1% penicillin/streptomycin. They were then digested 
mechanically and enzymatically with a 0.3% collagenase IV (Sigma) containing solution for 1 hour at 37ºC. 
 
Tumor sphere assays 
Sphere cultures were established from fresh total tumor cell preparations. After dissociation, tumor cells were 
plated on collagen-coated plates overnight, trypsinized next day and plated in 150 µl of sphere media (DMEM/F12 
with B27, 20 ng/ml EGF, 20 ng/ml FGF, 4 µg/ml heparin, 1% penicillin/streptomycin) with or without the small 
molecules at the indicated concentrations into 96-well low attachment plates (Cornig) at 1x104 cells per well and 
at least 5 wells per tumor. MMTV-PyMT spheres were counted after one week (7-10 days). Secondary 
mammosphere culture was performed by collecting the spheres through gentle centrifugation (800 rpm) followed 
by enzymatic (10 min in 0.05% trypsin-EDTA at 37°C) mechanical dissociation using a pipette. Mammospheres 
were stained with the indicated antibodies and images were taken with an inverted confocal microscope. 
 
Lentiviral production 
Lentiviral particles were produced in HEK293T cells by calcium phosphate precipitation. Briefly, two hours prior 
to transfection, 11x106 HEK293T cells/15 cm dish were incubated with DMEM+10%FBS supplemented with 25 
µM chloroquine (Sigma). Lentiviruses were produced by cotransfection of HEK293T cells with the vectors of 
interest together with the pCMV-dR8.74 and the pMD2G (VSVG). Next day, media was removed and replaced 
with fresh media containing 3 mM caffeine (Sigma). On the third day, the supernatant containing the viral particles 
was collected, ultracentrifuged for 2.5 hours at 20000 rpm to concentrate the lentiviruses and used to infect cells 
or aliquoted and stored at -80ºC.  
 
 
 FACS Analysis 
For FACSorting experiments, tumor cells derived from MMTV-PyMT mice were obtained by enzymatic 
disaggregation as described above. Cells were then washed twice with PBS, filtered (0.70 µM filters), stained 
with the appropriate antibodies for 30 minutes at 4ºC and sorted using either a FACSAria, a FACSAria III (BD 
Biosciences) or a MoFlo Astrios (Beckman Coulter). For FACS analysis, tumor cells were trypsinized, washed 
and stained with the appropriate antibodies for 30 minutes at 4ºC. DAPI or 7-AAD were used to discard dead 
cells. ALDH activity was tested using the AldeFluorTM assay kit (Stem Cell Technologies) as per the 
manufacturer's protocol. Briefly, cells were incubated with either the AldeFluorTM reagent alone or the 
AldeFluorTM reagent and the inhibitor diethylaminobenzaldehyde (DEAB) for 30 minutes at 37ºC. Cells were 
then centrifuged, washed and immunophenotyped when required. Fluorescence was analysed using either a Cyan 
ADP (Dako) or a MACSQuant (Miltenyi) instrument. Data was processed and analysed using FlowJo. 
 
Immunostaining 
MMTV-PyMT cells were grown on glass cover-slips, treated with vehicle (DMSO) or 2 µM SB431542 for 5 days 
and then fixed with 4% PFA for 15 minutes and subsequently washed with PBS. The unspecific binding of the 
antibodies was blocked using a solution containing 10% serum for 1 hour at room temperature. Samples were 
then incubated with primary antibodies for 1 hour at room temperature, washed 3 times with 1x PBS and incubated 
with a secondary antibody conjugated to AlexaFluor-488 for 1 hour at room temperature in a humid-chamber 
protected from light. Cell nuclei were stained with DAPI. Fluorescent images were taken with a LSM700 inverted 
confocal microscope (Zeiss), setting the pinhole at 1 AU.  
 
Western blot 
Protein was extracted with complete RIPA buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 
1 mM EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 
1 mM Na3VO4, 1 µg/ml leupeptin; Cell Signaling), separated by electrophoresis, transferred to PVDF membranes 
(Millipore), blocked with 5% BSA (Carl Roth) in 0.1% Tween 20 containing Tris-buffered saline (TBST) and 
incubated overnight with primary antibodies. Immunoreactive bands were visualized using HRP-conjugated 
secondary antibodies (Cell Signaling and Dako).  
 
Real-time PCR 
RNA was prepared using the mini or micro RNA kit (Qiagen) as per the manufacturer's instructions. cDNAs were 
generated using oligo-T priming and the M-MLV Reverse Transcriptase RNase H (-) Point Mutant (Promega). 
qPCR was performed in a StepOnePlus thermocycler (Applied Biosystems) using the SYBR green PCR Master 
Mix (Kapa) and following the manufacturer's instructions. A list of primers used is shown in Supplemental File 
5: Table 1. 
 
MTT assay 
MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium bromide] solution was prepared at 5 mg/ml in PBS. 
MMTV-PyMT cells were plated in 96 well plates in DMEM/F12 supplemented with 2% FBS, 20 ng/ml EGF, 10 
µg/ml insulin and 1/10 vol of MTT solution was added to the medium. Cells were incubated for 4 hours at 37ºC, 
then media was removed and replaced with 200 µl of DMSO. The dye was completely dissolved by pipetting and 



















 Supplemental File 5. Table 1: Primer Sets Used in This Study. 
 
 
ID Forward 5’-3’ Reverse 5’-3’ 
Rplp0 GATTCGGGATATGCTGTTGG GTTCTGAGCTGGCACAGTGA 
Krt18 CGAGGCACTCAAGGAAGAAC AATCTGGGCTTCCAGACCTT 
Tgfbr1 AAATTGCTCGACGCTGTTCT CAACCGATGGATCAGAAGGT 
Aldh1a3 GAGCGATCCTGGCTACTCTG GACGAAAAAGGCATGAAGGA 
Sox9 CAGCAAGACTCTGGGCAAG TCCACGAAGGGTCTCTTCTC 
Gata3 GCTACGGTGCAGAGGTATCC AGAGATCCGTGCAGCAGAG 
Mmp2 ACACTGGGACCTGTCACTCC TGTCACTGTCCGCCAAATAA 
Mmp9 CCAGATGATGGGAGAGAAGC TTGAGGCCTTTGAAGGTTTG 
Snai2 GAACCCACACATTGCCTTGT GCAGAAGCGACATTCTGGAG 
Zeb2 CTATTCCCCTGCATCAGCAT GGCTTGTCAGTCCTTTCTCG 
Vim GCGAGGAGAGCAGGATTTCTC GGGTGTCAACCAGAGGAAGT 
Fn1 TGCACGTGTGTGGGGAACGG CCCGGCCCTGACCAAAGCAG 
Pdgfb TGGTATCACTCCTGGAAGCC AACAGAAGACAGCGAGGTGG 
 
